Does LOSARTAN Cause Immune thrombocytopenia? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Immune thrombocytopenia have been filed in association with LOSARTAN (Losartan Potassium). This represents 0.1% of all adverse event reports for LOSARTAN.
17
Reports of Immune thrombocytopenia with LOSARTAN
0.1%
of all LOSARTAN reports
0
Deaths
9
Hospitalizations
How Dangerous Is Immune thrombocytopenia From LOSARTAN?
Of the 17 reports, 9 (52.9%) required hospitalization, and 11 (64.7%) were considered life-threatening.
Is Immune thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOSARTAN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does LOSARTAN Cause?
Drug ineffective (1,640)
Dizziness (1,553)
Headache (1,256)
Dyspnoea (1,185)
Malaise (1,149)
Hypotension (1,139)
Fatigue (1,116)
Acute kidney injury (1,100)
Cough (1,073)
Blood pressure increased (950)
What Other Drugs Cause Immune thrombocytopenia?
RITUXIMAB (335)
ALEMTUZUMAB (299)
PEMBROLIZUMAB (205)
DEXAMETHASONE (202)
ELTROMBOPAG OLAMINE (161)
NIVOLUMAB (151)
ROMIPLOSTIM (145)
OXALIPLATIN (141)
METHOTREXATE (132)
PREDNISONE (127)
Which LOSARTAN Alternatives Have Lower Immune thrombocytopenia Risk?
LOSARTAN vs LOSARTAN\LOSARTAN
LOSARTAN vs LOTEPREDNOL ETABONATE
LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN
LOSARTAN vs LOTILANER
LOSARTAN vs LOVASTATIN